GB2365338B - Therapeutic systems - Google Patents
Therapeutic systemsInfo
- Publication number
- GB2365338B GB2365338B GB0126082A GB0126082A GB2365338B GB 2365338 B GB2365338 B GB 2365338B GB 0126082 A GB0126082 A GB 0126082A GB 0126082 A GB0126082 A GB 0126082A GB 2365338 B GB2365338 B GB 2365338B
- Authority
- GB
- United Kingdom
- Prior art keywords
- therapeutic systems
- therapeutic
- systems
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Revoked
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/455—Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/68—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
- A61K47/6801—Drug-antibody or immunoglobulin conjugates defined by the pharmacologically or therapeutically active agent
- A61K47/6803—Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates
- A61K47/6811—Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates the drug being a protein or peptide, e.g. transferrin or bleomycin
- A61K47/6815—Enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9712370.7A GB9712370D0 (en) | 1997-06-14 | 1997-06-14 | Therapeutic systems |
GB9928237A GB2341605B (en) | 1997-06-14 | 1998-06-15 | Therapeutic systems |
Publications (3)
Publication Number | Publication Date |
---|---|
GB0126082D0 GB0126082D0 (en) | 2001-12-19 |
GB2365338A GB2365338A (en) | 2002-02-20 |
GB2365338B true GB2365338B (en) | 2002-04-03 |
Family
ID=26311719
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB0126082A Revoked GB2365338B (en) | 1997-06-14 | 1998-06-15 | Therapeutic systems |
Country Status (1)
Country | Link |
---|---|
GB (1) | GB2365338B (en) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0517957D0 (en) | 2005-09-03 | 2005-10-12 | Morvus Technology Ltd | Method of combating infection |
GB0526552D0 (en) | 2005-12-29 | 2006-02-08 | Morvus Technology Ltd | New use |
GB2442202A (en) | 2006-09-30 | 2008-04-02 | Morvus Technology Ltd | Vermin poison |
CA3142658A1 (en) * | 2019-06-05 | 2020-12-10 | Societe Des Produits Nestle S.A. | Reduced nicotinamideribosides for treating or preventing kidney disease |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5087618A (en) * | 1982-05-18 | 1992-02-11 | University Of Florida | Redox carriers for brain-specific drug delivery |
WO1999006436A1 (en) * | 1997-07-31 | 1999-02-11 | Elan Pharmaceuticals, Inc. | Benzyl compounds which inhibit leukocyte adhesion mediated by vla-4 |
-
1998
- 1998-06-15 GB GB0126082A patent/GB2365338B/en not_active Revoked
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5087618A (en) * | 1982-05-18 | 1992-02-11 | University Of Florida | Redox carriers for brain-specific drug delivery |
WO1999006436A1 (en) * | 1997-07-31 | 1999-02-11 | Elan Pharmaceuticals, Inc. | Benzyl compounds which inhibit leukocyte adhesion mediated by vla-4 |
Non-Patent Citations (1)
Title |
---|
CAPLUS Abstract Accession No. 1992:98883 & Med. Chem. Res. Vol. 1, No. 1, 1991, pages 80-85 * |
Also Published As
Publication number | Publication date |
---|---|
GB2365338A (en) | 2002-02-20 |
GB0126082D0 (en) | 2001-12-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EG24678A (en) | Combination therapy | |
DE69804447D1 (en) | Lithographisches system | |
EP0983104A4 (en) | Catheter system | |
IL127306A0 (en) | Combination therapy | |
GB9700939D0 (en) | Therapy | |
PL325324A1 (en) | Heasting system | |
GB9723999D0 (en) | Therapeutic use | |
GB2365338B (en) | Therapeutic systems | |
GB9708254D0 (en) | Construction system | |
GB9726701D0 (en) | Therapeutic use | |
GB9715487D0 (en) | Mearsurement system | |
ZA977005B (en) | Therapeutic uses | |
GB9726702D0 (en) | Therapeutic use | |
GB2329335B (en) | Medicament | |
GB9709750D0 (en) | System | |
TW367030U (en) | Ice-adding system | |
GB9704885D0 (en) | Therapy | |
GB9704156D0 (en) | Expression system | |
GB9718816D0 (en) | Extracorporeal system | |
GB9702946D0 (en) | Medicament | |
GB0002424D0 (en) | Medicament | |
GB9726234D0 (en) | Medicament | |
GB9705805D0 (en) | Integrated sprinkler system | |
PL323010A1 (en) | Labirinth-type totary blocking system | |
GB9722576D0 (en) | Improved system |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
727 | Application made for amendment of specification (sect. 27/1977) | ||
727A | Application for amendment of specification now open to opposition (sect. 27/1977) | ||
727B | Case decided by the comptroller ** specification amended (sect. 27/1977) | ||
773K | Patent revoked under sect. 73(2)/1977 |
Free format text: PATENT REVOKED ON 20070719 |